Minimal requirements for inhibition of MraY by lysis protein E from bacteriophage ΦX174

Shiho Tanaka1, William M Clemons

  • 1Division of Chemistry and Chemical Engineering, California Institute of Technology, M/C 114-96, Pasadena, CA 91125, USA.

Insights

Bacterial lysis protein E from phage ΦX174 uses its transmembrane helix to inhibit peptidoglycan synthesis by binding MraY. This mechanism provides a foundation for developing novel antimicrobial peptides.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • The DNA phage ΦX174 produces integral membrane protein E.
  • Protein E inhibits the peptidoglycan synthesis enzyme MraY, leading to host cell lysis.
  • Peptidoglycan synthesis inhibition is a known antimicrobial strategy.

Purpose of the Study:

  • To elucidate the molecular mechanism of protein E-mediated bacterial cell lysis.
  • To identify the key regions and residues of protein E involved in MraY inhibition.
  • To characterize the interaction between protein E and MraY.

Main Methods:

  • Site-directed mutagenesis of the conserved transmembrane helix of protein E.
  • Analysis of the lytic activity of mutant protein E variants.
  • Characterization of the complex formed between protein E and MraY.

Main Results:

  • A minimal 18-residue region within the transmembrane helix of protein E is sufficient for host cell lysis.
  • Specific residues within and at the boundaries of this helix are critical for lytic activity.
  • Protein E forms a stable complex with MraY, indicating a direct interaction.

Conclusions:

  • The precise positioning of the transmembrane helix of protein E within the membrane is crucial for its interaction with MraY.
  • Understanding the E-MraY interaction mechanism offers insights into developing new antimicrobial agents.
  • Re-engineered E peptides could serve as a basis for novel antimicrobial strategies targeting bacterial cell wall synthesis.